Daxor Corporation

09/30/2025

🏆 The Standard of Care Just Changed: Data from HFSA Validates BVA as Essential Diagnostic.

"Clinical findings provide undeniable evidence that BVA is an essential diagnostic for improving care and reducing costs,” – John L. Jefferies, MD, MPH, MBA, CMO.

This definitive statement follows the debut of our FDA-cleared, next-generation BVA analyzer and the presentation of pivotal data:

✅ Banner UMC: Showed ZERO unplanned readmissions for patients guided by BVA.

✅ Wellstar Health: Demonstrated substantial cuts in AKI/RRT, readmissions, and length of stay for LVAD patients.

✅ Geisinger Medical Center: Showed BVA identifies a unique phenotype in cardiac amyloidosis, assisting clinicians with accurate diuretic dosing.

This substantial clinical validation positions Daxor to ensure BVA technology becomes widely accessible, making its benefits available to all patients.

Read more: https://daxor.com/daxor-unveils-new-fda-cleared-bva-analyzer-amid-strong-market-demand-and-pivotal-clinical-data-at-hfsa/

Nasdaq
Banner Health
Geisinger
Wellstar Health System

09/25/2025

The problem of imprecise fluid management is the inability to precisely measure blood volume. Our new BVA system solves this with over 95% accuracy in a rapid, lightweight, battery-operated device. See it at Device Day & Booth #1007 at .

09/23/2025

🎉We're headed to for the official debut of our new, FDA-cleared BVA analyzer. This next-gen device is a game-changer for data-driven fluid management. Read more: https://daxor.com/daxor-corporation-unveils-breakthrough-next-gen-bva-analyzer-at-hfsa-annual-scientific-meeting/
Nasdaq

09/22/2025

"Blood Volume Analysis is like an EKG for volume" - my colleague's insight perfectly captures where precision medicine is heading. Read more: https://www.linkedin.com/posts/daxorcorporation_bva-heartfailure-activity-7375876541596979200-vuVi?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAMGo4ABzJtW1kRfkqctXbzjRcnEurq3iSM

09/19/2025

Attending HFSA 2025? So are we! Stop by Device Day or find us at booth 1007 for a live demonstration of our new BVA analyzer. We're looking forward to connecting with you and sharing this exciting advancement.

09/04/2025

Learn how our technology is changing . A new pilot study published in the Journal of Critical Care reveals frequent inaccuracies in traditional fluid assessments, reinforcing the need for our solution.
Read more: https://daxor.com/5716-2/?utm_source=mailpoet&utm_medium=email&utm_source_platform=mailpoet

Nasdaq

09/03/2025

Connect with our CEO, Michael Feldschuh. He will be taking one-on-one meetings, and an on-demand presentation is available starting September 5.
Read for details: https://daxor.com/daxor-corporation-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/

09/02/2025

Mid-year are in! Our CEO has shared an update on our first-half performance in a new letter to shareholders. Find all the details here: https://lnkd.in/eNHYvYNs
Nasdaq

09/01/2025

Today, we celebrate the hard work, dedication, and contributions of our incredible team and workers everywhere. 🙌

08/28/2025

Please join us in giving a warm welcome to Beth, the newest member of the Daxor Team! We're thrilled to have her onboard and can't wait to see all that she accomplishes. Welcome, Beth! 🥳

08/26/2025

🤔What if we could simplify the most complex patient management scenarios?

📖Read more: https://linkedin.com/posts/daxorcorporation_what-if-we-could-simplify-the-most-complex-activity-7366092124120924160-gl4_?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAMGo4ABzJtW1kRfkqctXbzjRcnEurq3iSM

08/25/2025

📺 In this news story, our Chief Medical Officer, Dr. John Jefferies, discusses the critical importance of optimal blood volume for patient health. Link here: https://www.wfla.com/video/do-you-know-your-true-blood-volume-status-bloom/11007480/
WFLA News Channel 8

Gayle Guyardo, host of Bloom, sat down with the Chief Medical Officer of Daxor Corporation, Dr. John L. Jefferies to discuss the power of Blood Volume Analysis.